全文获取类型
收费全文 | 109168篇 |
免费 | 7899篇 |
国内免费 | 324篇 |
专业分类
耳鼻咽喉 | 1320篇 |
儿科学 | 2734篇 |
妇产科学 | 2436篇 |
基础医学 | 13735篇 |
口腔科学 | 2227篇 |
临床医学 | 10831篇 |
内科学 | 23177篇 |
皮肤病学 | 1199篇 |
神经病学 | 10099篇 |
特种医学 | 3751篇 |
外国民族医学 | 3篇 |
外科学 | 17332篇 |
综合类 | 1546篇 |
现状与发展 | 1篇 |
一般理论 | 86篇 |
预防医学 | 9009篇 |
眼科学 | 2919篇 |
药学 | 7086篇 |
中国医学 | 163篇 |
肿瘤学 | 7737篇 |
出版年
2023年 | 401篇 |
2022年 | 627篇 |
2021年 | 1786篇 |
2020年 | 961篇 |
2019年 | 1714篇 |
2018年 | 2057篇 |
2017年 | 1522篇 |
2016年 | 1715篇 |
2015年 | 2020篇 |
2014年 | 2936篇 |
2013年 | 4618篇 |
2012年 | 6646篇 |
2011年 | 6940篇 |
2010年 | 3895篇 |
2009年 | 3581篇 |
2008年 | 6571篇 |
2007年 | 7277篇 |
2006年 | 6968篇 |
2005年 | 7122篇 |
2004年 | 6950篇 |
2003年 | 6546篇 |
2002年 | 6539篇 |
2001年 | 1022篇 |
2000年 | 879篇 |
1999年 | 1057篇 |
1998年 | 1405篇 |
1997年 | 1231篇 |
1996年 | 1081篇 |
1995年 | 1064篇 |
1994年 | 921篇 |
1993年 | 826篇 |
1992年 | 764篇 |
1991年 | 717篇 |
1990年 | 719篇 |
1989年 | 634篇 |
1988年 | 626篇 |
1987年 | 601篇 |
1986年 | 589篇 |
1985年 | 650篇 |
1984年 | 829篇 |
1983年 | 864篇 |
1982年 | 1066篇 |
1981年 | 1011篇 |
1980年 | 928篇 |
1979年 | 534篇 |
1978年 | 605篇 |
1977年 | 628篇 |
1976年 | 529篇 |
1975年 | 485篇 |
1974年 | 393篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
Philippe A. Eigenmann Motohiro Ebisawa Matthew Greenhawt Jonathan O’B Hourihane Tamara T. Perry Benjamin C. Remington Robert A. Wood 《Pediatric allergy and immunology》2021,32(4):658-666
Risk is a concept inherent in every medical procedure. It can be defined as the probability of an adverse event in a defined population over a specified period of time. In the frame of food allergy management, it might be related to a diagnostic procedure, a treatment, or the consumption of foods. The risk of an adverse event can also be augmented by individual factors. This rostrum article discusses various aspects faced by children with food allergies in the light of risk, and their practical implications. Identifying personal risks for severe reaction, such as unstable asthma, and correcting them whenever possible also contribute to a reduction of the risk inherent to food allergy. Among the facets discussed, oral food challenges (OFC) are the most common diagnostic procedures implying an inherent risk. The risk of OFCs can be minimized by correct indication and timing of the test, a safe setting, as well as by ensuring that the patient is otherwise well without potential stressor potentially increasing the risk of a more severe reaction. Oral immunotherapy (OIT) has been studied as a potential treatment for increasing the threshold dose for reaction, and thus reducing the risk of accidental reaction. Nevertheless, the procedure is not devoid of risk as the patients may and do often react during the course of the procedure. Ingestion of trace amounts in processed foods, mainly in community settings such as restaurants, schools, or day care, represents a potential risk of reactions, although for a minority of patients. Precautionary allergen labeling (PAL) is a widespread strategy to reduce the potential risk of reactions due to traces. However, PAL is currently inefficient due to inconsistent labeling, also not indicating a clear maximum amount possibly present in the manufactured food. Finally, cost-effectiveness needs to be considered in risk management, as many risk reduction procedures are clearly not cost-effective. 相似文献
32.
33.
34.
35.
36.
37.
Marlene L Hauck Susan M LaRue William P Petros Jean M Poulson Daohai Yu Ivan Spasojevic Amy F Pruitt Allison Klein Beth Case Donald E Thrall David Needham Mark W Dewhirst 《Clinical cancer research》2006,12(13):4004-4010
PURPOSE: To determine the maximum tolerated dose, dose-limiting toxicities, and pharmacokinetic characteristics of doxorubicin encapsulated in a low temperature sensitive liposome (LTSL) when given concurrently with local hyperthermia to canine solid tumors. EXPERIMENTAL DESIGN: Privately owned dogs with solid tumors (carcinomas or sarcomas) were treated. The tumors did not involve bone and were located at sites amenable to local hyperthermia. LTSL-doxorubicin was given (0.7-1.0 mg/kg i.v.) over 30 minutes during local tumor hyperthermia in a standard phase I dose escalation study. Three treatments, given 3 weeks apart, were scheduled. Toxicity was monitored for an additional month. Pharmacokinetics were evaluated during the first treatment cycle. RESULTS: Twenty-one patients were enrolled: 18 with sarcomas and 3 with carcinomas. Grade 4 neutropenia and acute death secondary to liver failure, possibly drug related, were the dose-limiting toxicities. The maximum tolerated dose was 0.93 mg/kg. Other toxicities, with the possible exception of renal damage, were consistent with those observed following free doxorubicin administration. Of the 20 dogs that received > or = 2 doses of LTSL-doxorubicin, 12 had stable disease, and 6 had a partial response to treatment. Pharmacokinetic variables were more similar to those of free doxorubicin than the marketed liposomal product. Tumor drug concentrations at a dose of 1.0 mg/kg averaged 9.12 +/- 6.17 ng/mg tissue. CONCLUSION: LTSL-doxorubicin offers a novel approach to improving drug delivery to solid tumors. It was well tolerated and resulted in favorable response profiles in these patients. Additional evaluation in human patients is warranted. 相似文献
38.
39.
Christine E. Marx William T. Trost Lawrence J. Shampine Robert D. Stevens Christine M. Hulette David C. Steffens John F. Ervin Marian I. Butterfield Daniel G. Blazer Mark W. Massing Jeffrey A. Lieberman 《Neuropsychopharmacology》2006,60(12):1287-1294
BACKGROUND: Few data are currently available investigating neurosteroids (NS) in Alzheimer's disease (AD). The NS allopregnanolone may be decreased in serum and plasma in patients with AD, but it is unclear if allopregnanolone is also reduced in brain. Because a number of NS exhibit neuroprotective effects and impact cognitive performance in rodent models, these molecules may be relevant to the pathophysiology of neurodegenerative disorders. We therefore investigated prefrontal cortex (PFC) NS levels in AD. METHODS: Neurosteroid levels (allopregnanolone, pregnenolone, dehydroepiandrosterone [DHEA]) were determined in postmortem PFC in 14 male subjects with AD and 15 cognitively intact male control subjects by gas chromatography/mass spectrometry preceded by high-performance liquid chromatography purification. RESULTS: Subjects with AD exhibit significant reductions in allopregnanolone compared with cognitively intact control subjects (median levels = 2.50 ng/g vs. 5.59 ng/g, respectively; p = .02). Allopregnanolone levels are inversely correlated with neuropathological disease stage (Braak), r = -.49, p = .007. Median DHEA levels are elevated in subjects with AD (p = .01). CONCLUSIONS: Subjects with AD demonstrate significant reductions in PFC allopregnanolone levels, a finding that may be relevant to neuropathological disease stage severity. Neurosteroids may have utility as candidate biomarkers in AD. 相似文献
40.